Detalles de la búsqueda
1.
Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction.
Int J Clin Pract
; 75(4): e13945, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338308
2.
Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment.
J Formos Med Assoc
; 120(1 Pt 3): 621-628, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32718890
3.
Combined Chibby and ß-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Int J Mol Sci
; 21(6)2020 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32192213
4.
A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial.
J Antimicrob Chemother
; 74(6): 1718-1724, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768161
5.
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection.
BMC Cancer
; 19(1): 1169, 2019 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791275
6.
Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.
J Formos Med Assoc
; 118(1 Pt 3): 504-513, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30527565
7.
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.
Liver Int
; 38(6): 1064-1073, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164767
8.
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy.
J Formos Med Assoc
; 117(11): 1011-1018, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29254684
9.
Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.
J Formos Med Assoc
; 117(4): 268-275, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947134
10.
Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
J Formos Med Assoc
; 117(9): 833-840, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089161
11.
The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice.
J Formos Med Assoc
; 116(11): 852-861, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28888355
12.
Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.
J Antimicrob Chemother
; 71(7): 1943-7, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27073265
13.
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Clin Gastroenterol Hepatol
; 13(5): 1017-24, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460552
14.
The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
J Gastroenterol Hepatol
; 30(2): 345-51, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092265
15.
Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections.
Arch Virol
; 159(1): 29-37, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857507
16.
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Am J Kidney Dis
; 62(4): 789-95, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23746377
17.
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral.
Viruses
; 14(12)2022 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560675
18.
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection.
Liver Cancer
; 11(1): 22-37, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222505
19.
Significant association between serum Wisteria floribunda agglutinin-positive Mac-2-binding protein and prognosis of hepatocellular carcinoma after surgical treatment.
Am J Cancer Res
; 12(2): 601-614, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35261790
20.
Comparison of tenofovir and entecavir in the development of acute kidney injury in cirrhotic chronic hepatitis B patients with refractory ascites.
Eur J Gastroenterol Hepatol
; 32(2): 208-213, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32371826